Latent tuberculosis infection (LTBI) has become a major source of active tuberculosis (ATB).
Although the tuberculin skin test and interferon-gamma release assay can be used to …

Accurate tuberculosis (TB) diagnosis remains challenging, especially in resource-limited
settings. This study aims to assess the diagnostic performance of the QIAreach …

Tuberculosis (TB) transmission and prevalence are dynamic over time, and heterogeneous
within populations. Public health programmes therefore require up-to-date, accurate …

Tuberculosis (TB) is the leading cause of death from a single infectious agent. The burden is
highest in some low-and middle-income countries. One-quarter of the world's population is …

Background Although the incidence of non-tuberculous mycobacterial pulmonary disease
(NTM-PD) is increasing annually, it is easily misdiagnosed as pulmonary tuberculosis (PTB) …

Background The clinical challenge of differentiating suspected tuberculosis with positive T-
SPOT. TB results persist. This study aims to investigate the utility of the Systemic Immune …

Urgent improvements in the diagnosis and management of Mycobacterium tuberculosis
infection are required to reach End TB goals. Conventional interferon-gamma release …

Despite the existing effective treatment methods, tuberculosis (TB) is the second most
deadly infectious disease, its carriers in the latent and active phases accounting for more …

Objectives In the post‐SARS‐CoV‐2 pandemic era,“breakthrough infections” are still
documented, due to variants of concerns (VoCs) emergence and waning humoral immunity …

Purpose: High-accuracy diagnostic screening tests for Mycobacterium tuberculosis (MTB)
infection are required, primarily to detect patients with latent infections (LTBIs) in order to …